BRBryan Renslo

Bryan Renslo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bryan Renslo has a total of 106 co-authors. Here are the top co-authors by number of shared publications:

  • Andres M. Bur

    Department of Otolaryngology – Head and Neck Surgery University of Kansas Medical Center Kansas City Kansas USA

    6 shared publications
  • Tuleen Sawaf

    Department of Otolaryngology‐Head & Neck Surgery University of Maryland Baltimore Maryland U.S.A.

    4 shared publications
  • Celina G. Virgen

    Department of Otolaryngology—Head & Neck Surgery, University of Kansas Medical Center, Kansas City, Kansas

    3 shared publications
  • Kevin J. Sykes

    Department of Otolaryngology—Head & Neck Surgery, University of Kansas Medical Center, Kansas City, Kansas

    3 shared publications
  • Tuleen Sawaf

    Department of Otolaryngology- Head and Neck Surgery, University of Kansas Medical Center, Kansas City, KS

    3 shared publications
  • Amelia Lawrence

    Department of Otolaryngology‐Head & Neck Surgery University of Kansas Medical Center Kansas City Kansas U.S.A.

    2 shared publications

Latest Publications

  • Performance of In-Office Laryngeal Procedures Using Single-Use Endoscopes

    by Hannah L. Kenny, Bryan Renslo, Emily A. Garvey, Kathleen M. Tibbetts

  • Open Access

    Validity of Activity-Based Checks (ABCs) of Pain, A Functional Pain Scale

    by Celina G. Virgen, Robert Wright, Bryan Renslo, Tuleen Sawaf, Hanna Moradi, Maria Edelen, Jennifer Villwock


  • Outcomes of Microvascular Free Flap Reconstruction With One Versus Two Primary Surgeons

    by Jamison Macke, Tuleen Sawaf, Natalie Schelbar, Bryan Renslo, Heather Schopper, Kevin J. Sykes, Andres Bur, Justin Bond, Yelizaveta Shnayder, Terance T. Tsue, et al.

    Objective: To evaluate operative efficiency and quality in head and neck free flap reconstruction with one versus two primary surgeons by comparing procedure duration, hospital length of stay, complications and readmission rates.Study Design: Retrospective chart review.Setting: Single‐institution tertiary care centre.Methods: A total of 583 patients who received head and neck surgery with free flap reconstruction at the University of Kansas Medical Center between November 2010 and January 2021 were stratified into two cohorts: one‐surgeon cohort and two‐surgeon cohort. In the two‐surgeon cohort, one surgeon performed tissue resection and the second performed reconstruction (n = 329), whereas one primary surgeon performed both resection and reconstruction in the one‐surgeon cohort (n = 254). Patient age, sex, American Society of Anaesthesia (ASA) status and Charlson comorbidity index (CCI) at time of surgery were collected.Results: No significant difference in baseline clinicodemographic characteristics was found between groups. A reduced mean procedure duration was found in the one‐surgeon cohort (424.9 min, SD 127.6) compared to the two‐surgeon cohort (552.4 min, SD 119.2) (mean difference 127.5 min, Cohen d = 1.04). A slightly greater proportion of osteocutaneous free flaps was performed in the two‐surgeon cohort compared to the one‐surgeon cohort (one‐surgeon: 53.5%; two‐surgeon 62.3%). All other secondary quality measures showed nonsignificant differences with the exception of the proportion requiring intraoperative pressors (86.2% in one‐surgeon cohort vs. 74.5% in two‐surgeon cohort, mean difference 11.7%, Cohen d = 0.29).Conclusions: This study demonstrates at least noninferior efficiency and quality outcomes in free flap cases led by single primary surgeons at our institution. The optimal approach to maximise operative efficiency and quality likely differs across surgeons and centres.Level of Evidence: III.


  • Assessing the Reporting Quality of Machine Learning Algorithms in Head and Neck Oncology

    by Rahul Alapati, Bryan Renslo, Sarah F. Wagoner, Omar Karadaghy, Aisha Serpedin, Yeo Eun Kim, Maria Feucht, Naomi Wang, Uma Ramesh, Antonio Bon Nieves, et al.

    Objective: This study aimed to assess reporting quality of machine learning (ML) algorithms in the head and neck oncology literature using the TRIPOD‐AI criteria.Data Sources: A comprehensive search was conducted using PubMed, Scopus, Embase, and Cochrane Database of Systematic Reviews, incorporating search terms related to “artificial intelligence,” “machine learning,” “deep learning,” “neural network,” and various head and neck neoplasms.Review Methods: Two independent reviewers analyzed each published study for adherence to the 65‐point TRIPOD‐AI criteria. Items were classified as “Yes,” “No,” or “NA” for each publication. The proportion of studies satisfying each TRIPOD‐AI criterion was calculated. Additionally, the evidence level for each study was evaluated independently by two reviewers using the Oxford Centre for Evidence‐Based Medicine (OCEBM) Levels of Evidence. Discrepancies were reconciled through discussion until consensus was reached.Results: The study highlights the need for improvements in ML algorithm reporting in head and neck oncology. This includes more comprehensive descriptions of datasets, standardization of model performance reporting, and increased sharing of ML models, data, and code with the research community. Adoption of TRIPOD‐AI is necessary for achieving standardized ML research reporting in head and neck oncology.Conclusion: Current reporting of ML algorithms hinders clinical application, reproducibility, and understanding of the data used for model training. To overcome these limitations and improve patient and clinician trust, ML developers should provide open access to models, code, and source data, fostering iterative progress through community critique, thus enhancing model accuracy and mitigating biases.Level of Evidence: NA Laryngoscope, 135:687–694, 2025


  • Predicting Therapeutic Response to Hypoglossal Nerve Stimulation Using Deep Learning

    by Rahul Alapati, Bryan Renslo, Laura Jackson, Hanna Moradi, Jamie R. Oliver, Mohsena Chowdhury, Tejas Vyas, Antonio Bon Nieves, Amelia Lawrence, Sarah F. Wagoner, et al.

    Objectives: To develop and validate machine learning (ML) and deep learning (DL) models using drug‐induced sleep endoscopy (DISE) images to predict the therapeutic efficacy of hypoglossal nerve stimulator (HGNS) implantation.Methods: Patients who underwent DISE and subsequent HGNS implantation at a tertiary care referral center were included. Six DL models and five ML algorithms were trained on images from the base of tongue (BOT) and velopharynx (VP) from patients classified as responders or non‐responders as defined by Sher's criteria (50% reduction in apnea‐hypopnea index (AHI) and AHI < 15 events/h). Precision, recall, F1 score, and overall accuracy were evaluated as measures of performance.Results: In total, 25,040 images from 127 patients were included, of which 16,515 (69.3%) were from responders and 8,262 (30.7%) from non‐responders. Models trained on the VP dataset had greater overall accuracy when compared to BOT alone and combined VP and BOT image sets, suggesting that VP images contain discriminative features for identifying therapeutic efficacy. The VCG‐16 DL model had the best overall performance on the VP image set with high training accuracy (0.833), F1 score (0.78), and recall (0.883). Among ML models, the logistic regression model had the greatest accuracy (0.685) and F1 score (0.813).Conclusion: Deep neural networks have potential to predict HGNS therapeutic efficacy using images from DISE, facilitating better patient selection for implantation. Development of multi‐institutional data and image sets will allow for development of generalizable predictive models.Level of Evidence: NA Laryngoscope, 134:5210–5216, 2024


  • Functional Oral Intake in Primary Versus Salvage Laryngectomy

    by Anna C. Lawrence, Sarah King, Bryan Renslo, Tuleen Sawaf, Omar Karadaghy, Shannon Kraft

    Objective: Advanced‐stage laryngeal squamous cell carcinoma is treated with primary surgery or chemoradiation. We aim to determine if there are differences in postoperative functional oral intake in primary (PL) versus salvage laryngectomees (SL).Study Design: Retrospective cohort study.Setting: Patients who underwent laryngectomy between 2011 and 2021.Methods: We examined demographic, diagnostic, treatment, and swallow function data pre‐ and postoperatively. A follow‐up survey was distributed to assess current swallow status.Results: One hundred twenty‐five patients were included. Preoperatively, 68.8% of patients reported dysphagia. Median functional oral intake score (FOIS) was 4.0 [interquartile range, IQR: 1.0‐6.75]. The SL group had lower preop FOIS [2.0; IQR: 1.0‐4.75] that did not reach significance compared to the PL group [4.5; IQR: 1.0‐7.0] (P = .052). 73.4% of patients had a feeding tube. The PL group was more likely to have the tube removed [odds ratio, OR: 2.4; confidence interval, CI: 1.0‐5.7]. The SL group was more likely to require feeding tube placement more than 6 months postop [OR: 6.9; CI: 1.65‐32.6]. SL FOIS scores improved by 3 months postop to 5 (SL ΔFOIS = 3, P = .0150). PL scores improved to 7 [PL ΔFOIS = 2, P = .0005] at 12 to 15 months. Sixty‐nine patients were contacted for a follow‐up survey and 16 completed this survey. 30.4% patients reported dietary restrictions (mean 4.4 years postop).Conclusion: Patients undergoing SL appear to obtain similar swallow outcomes compared to PL at 3 to 6 months postlaryngectomy, but plateau. The PL group continues to improve up to 1 year postoperatively. Fifty percent of patients report on‐going dysphagia after 5 years.


  • Open Access

    Surgical evacuation for chronic subdural hematoma: Predictors of reoperation and functional outcomes

    by Georgios S. Sioutas, Ahmad Sweid, Ching-Jen Chen, Andrea Becerril-Gaitan, Fadi Al Saiegh, Kareem El Naamani, Rawad Abbas, Abdelaziz Amllay, Lyena Birkenstock, Rachel E. Cain, et al.


  • Open Access

    Abstract PO-043: Development of an automated multi-objective model utilizing delta radiomics to predict locoregional recurrence in head and neck cancer patients treated with primary radiation

    by Bryan Renslo, Ethan Kallenberger, Patrick Ioerger, Kenny Guida, Oluwatobiloba Ige, Omar Karadaghy, Gregory Gan, Zhiguo Zhou, Andres Bur

    Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer globally and is frequently treated with definitive radiotherapy. However, 15-50% of patients experience locoregional recurrence (LRR) within 3 years of treatment. The majority of recurrences develop within the first 2 years. Machine learning and deep learning have been utilized to predict oncologic treatment outcomes with high accuracy. Accurate prediction allows for the identification of high-risk patients prior to recurrence, allowing for more intensified monitoring and increased likelihood of long-term disease control. Radiomics is the extraction of quantitative data from radiologic images and provides information that is imperceptible to the human eye. Prior studies have successfully utilized pre- or post-treatment contrast enhanced CT (CECT) images to predict treatment outcomes in HNSCC in machine learning models. In this study, we utilize pre-treatment CECT radiomic features to build an automated multi-objective (AutoMO) model to predict LRR for patients with HNSCC treated with definitive radiotherapy. Patients with primary laryngeal, oropharyngeal, or hypopharyngeal cancer treated with primary radiotherapy from January 2018 through November 2020 were identified. Patients were excluded if they did not have a pre-treatment CECT within 3 months of initiation or a post-treatment CECT within 1-6 months of completion of radiotherapy. Pre- and post-treatment CECT scans as well as clinical information, including locoregional recurrence or progression within two years, were collected retrospectively. Pre-treatment CECT scans contoured for gross tumor volume (GTV) were also collected, which were utilized as the ground-truth reference for auto-contouring of pre-treatment scans. An AutoMO model was developed that maximizes both sensitivity and specificity simultaneously, offering more balanced results as compared to a model that reports the traditional area under the curve (AUC) metric. Following CECT image pre-processing, 275 radiomic features including intensity, texture and geometry were extracted in 3-dimensional volume from pre-treatment CECT scans. Image features were fed into the AutoMO model. 3-fold cross validation was performed, and hyperparameters were tuned to optimize model results. A total of 70 patients met inclusion criteria. The population was 81.4% male (n=57) with an average age of 64.4. Of all patients 22 (31.4%) were positive for recurrence or progression. The model achieved a sensitivity of 0.55, specificity of 0.83, accuracy of 0.79, and AUC of 0.65. The AutoMO model was moderately accurate for predicting recurrence or progression for patients with HNSCC utilizing pre-treatment CECT radiomics. Future iterations integrating clinical data, post-treatment images, and an increased sample size should improve model accuracy. Citation Format: Bryan Renslo, Ethan Kallenberger, Patrick Ioerger, Kenny Guida, Oluwatobiloba Ige, Omar Karadaghy, Gregory Gan, Zhiguo Zhou, Andres Bur. Development of an automated multi-objective model utilizing delta radiomics to predict locoregional recurrence in head and neck cancer patients treated with primary radiation [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Innovating through Basic, Clinical, and Translational Research; 2023 Jul 7-8; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2023;29(18_Suppl):Abstract nr PO-043.

  • Open Access

    Association of Social-Ecological Factors With Delay in Time to Initiation of Postoperative Radiation Therapy

    by Tuleen Sawaf, Celina G. Virgen, Bryan Renslo, Nathan Farrokhian, Katherine M. Yu, Shaan N. Somani, Andrés M. Bur, Kiran Kakarala, Yelizaveta Shnayder, Gregory N. Gan, et al.

    Importance: Timely initiation of postoperative radiation therapy (PORT) is associated with reduced recurrence rates and improved overall survival in patients with head and neck squamous cell carcinoma (HNSCC). Measurement of the association of social-ecological variables with PORT delays is lacking.Objective: To assess individual and community-level factors associated with PORT delay among patients with HNSCC.Design, Setting, and Participants: This prospective cohort study carried out between September 2018 and June 2022 included adults with untreated HNSCC who were enrolled in a prospective registry at a single academic tertiary medical center. Demographic information and validated self-reported measures of health literacy were obtained at baseline visits. Clinical data were recorded, and participant addresses were used to calculate the area deprivation index (ADI), a measure of community-level social vulnerability. Participants receiving primary surgery and PORT were analyzed. Univariable and multivariable regression analysis was performed to identify risk factors for PORT delays.Exposures: Surgical treatment and PORT.Main Outcomes and Measures: The primary outcome was PORT initiation delay (>42 days from surgery). Risk of PORT initiation delay was evaluated using individual-level (demographic, health literacy, and clinical data) and community-level information (ADI and rural-urban continuum codes).Results: Of 171 patients, 104 patients (60.8%) had PORT delays. Mean (SD) age of participants was 61.0 (11.2) years, 161 were White (94.2%), and 105 were men (61.4%). Insurance was employer-based or public among 65 (38.5%) and 75 (44.4%) participants, respectively. Mean (SD) ADI (national percentile) was 60.2 (24.4), and 71 (41.8%) resided in rural communities. Tumor sites were most commonly oral cavity (123 [71.9%]), with 108 (63.5%) classified as stage 4 at presentation. On multivariable analysis, a model incorporating individual-level factors with health literacy in addition to community-level factors was most predictive of PORT delay (AOC= 0.78; R2, 0.18).Conclusions and Relevance: This cohort study provides a more comprehensive assessment of predictors of PORT delays that include health literacy and community-level measures. Predictive models that incorporate multilevel measures outperform models with individual-level factors alone and may guide precise interventions to decrease PORT delay for at-risk patients with HNSCC.


  • Long-term trends in body mass index throughout upper airway stimulation treatment: does body mass index matter?

    by Bryan Renslo, Celina G. Virgen, Tuleen Sawaf, Alexandra Arambula, Kevin J. Sykes, Christopher Larsen, David T. Rouse

    Upper airway stimulation is a surgical option for patients with obstructive sleep apnea who fail other forms of noninvasive treatment. Current guidelines recommend a baseline body mass index (BMI) below 32 kg/m2 for eligibility. In this study, we identify trends in BMI before and after upper airway stimulation to characterize the influence of BMI on treatment success. Patients underwent upper airway stimulation implantation between 2016 and 2021. Sleep study data were collected from preoperative and most recent postoperative sleep study. BMI data were collected and compared across the following time points: preoperative sleep study (BMI-1), initial surgeon consultation (BMI-2), surgery (BMI-3), titration polysomnogram (BMI-4), and second postoperative sleep study (BMI-5). Patients were categorized into groups (BMI ≥32 [BMI32], 25 ≤ BMI 25], BMI 18]) based BMI-1, and clinical outcomes were compared. 253 patients were included. The BMI32 group showed a significant decrease in BMI between BMI-1 and BMI-3 (33.9 vs 32.2; P < .001) and a significant increase in BMI between BMI-3 and BMI-5 (32.2 vs 33.0; P = .047). Apnea-hypopnea index improvement and treatment success rate were not significantly different between groups. On univariate and multivariable logistic regression, a lower BMI-5 was significantly predictive of treatment success (odds ratio: 0.88; 95% confidence interval: 0.79-0.97; P = .016). BMI-5 was also significantly associated with improvement in apnea-hypopnea index (P = .002). Other BMI time points were not associated with measures of treatment success. Reduced BMI after upper airway stimulation implantation, as opposed to baseline BMI, predicted treatment success. These findings may guide patient counseling, with implications for long-term adherence and therapy success. Renslo B, Virgen CG, Sawaf T, et al. Long-term trends in body mass index throughout upper airway stimulation treatment: does body mass index matter? J Clin Sleep Med. 2023;19(6):1061-1071.